http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0af718eb926992f91ddf45c815b8727e
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Menendez |
| name | Javier A. Menendez Javier A Menendez |
| given-name | Javier A. Javier A |
| organization-name | Girona Biomedical Research Institute (IDIBGI), Molecular Oncology Group, Girona, Catalonia, Spain; Translational Research Laboratory, Catalan Institute of Oncology (ICO), Girona, Catalonia, Spain Catalan Institute of Oncology, Girona (Catalonia, Spain); Girona Biomedical Research Institute, Girona (Catalonia, Spain) Department of Medicine, Evanston Northwestern Healthcare Research Institute, Evanston, IL 60201, USA. Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Catalonia, Spain; Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Catalonia, Spain Girona Biomedical Research Institute, Girona, Catalonia, Spain; ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism & Cancer Group, Catalan Institute of Oncology, Girona, Catalonia, Spain Catalan Institute of Oncology (ICO Girona), Health Services Division of Catalonia, Dr Josep Trueta University Hospital of Girona, Girona, Catalonia, Spain ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain; Girona Biomedical Research Institute (IDIBGI), Girona, Spain Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain; Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain; Metabostem, Barcelona, Spain ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism & Cancer Group, Catalan Institute of Oncology (ICO), Girona, Spain; Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain Metabolism & Cancer Group; Translational Research Laboratory; Catalan Institute of Oncology; Girona, Spain; Molecular Oncology Group; Girona Biomedical Research Institute; Girona, Spain Metabolism & Cancer Group; Translational Research Laboratory; Catalan Institute of Oncology (ICO); Girona; Catalonia, Spain; Girona Biomedical Research Institute (IDIBGI); Girona, Catalonia, Spain ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism & Cancer Group, Catalan Institute of Oncology, Girona, Spain; Girona Biomedical Research Institute (IDIBGI), Parc Hospitalari Martí i Julià, Girona, Spain Catalan Institute of Oncology, Girona Biomedical Research Institute, Hospital Universitari de Girona Josep Trueta, Girona, Catalonia, Spain Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology (ICO), Girona, Spain; Girona Biomedical Research Institute (IDIBGI), Girona, Spain Catalan Institute of Oncology and Girona Biomedical Research Institute, Avda de Francia s/n, 17007 Girona, Spain Girona Biomedical Research Institute (IdIBGi), Salt, 17190 Girona, Spain; Metabolism & Cancer Group, ProCURE, Catalan Institute of Oncology, 17007 Girona, Spain Department of Medicine, Evanston Northwestern Healthcare, 1001 University Place, Evanston, IL 60201; Feinberg School of Medicine, Northwestern University, 303 East Chicago Avenue, Chicago, IL 60611; Cancer Epigenetics Laboratory, Molecular Pathology Program, Spanish National Cancer Center (CNIO), Melchor Fernandez Almagro 3, E-28029, Madrid, Spain; and Institut Catala d'Oncologia, Hospital Universitari Dr. Josep Trueta, Avinguda de Franca s/n, E-17007 Girona, Spain Catalan Institute of Oncology (ICO), Girona Biomedical Research Institute (IdIBGi), Spain. jmenendez@ico.scs.es Catalan Institute of Oncology and Girona Biomedical Research Institute Girona Spain Metabolism and Cancer Group, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology, Girona, Spain; Girona Biomedical Research Institute (IDIBGI), Girona, Spain ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Catalonia, Spain; Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Catalonia, Spain Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Catalonia, Spain; Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain Department of Medicine, Evanston Northwestern Research Institute, Evanston, IL 60201, USA. Metabolism and Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology-Girona (ICO-Girona); Molecular Oncology, Girona Biomedical Research Institute (IDIBGi) ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Catalonia, Spain; Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain Girona Biomedical Research Institute, Girona (Catalonia, Spain); Unit of Translational Research, Catalan Institute of Oncology, Girona (Catalonia, Spain) ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Catalonia, Spain; Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Salt, Catalonia, Spain Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology-Girona (ICO-Girona), Girona, Spain; Molecular Oncology, Girona Biomedical Research Institute (IDIBGi), Girona, Spain ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism & Cancer Group, Catalan Institute of Oncology, Girona, Catalonia, Spain; Girona Biomedical Research Institute (IDIBGI), Girona, Catalonia, Spain Catalan Institute of Oncology (ICO), Girona, Catalonia, Spain.; Girona Biomedical Research Institute (IdIBGi), Girona, Catalonia, Spain and University Hospital of Girona Dr. Josep Trueta, Girona, Catalonia, Spain. Catalan Institute of Oncology-Health Services Division of Catalonia; Girona Biomedical Research Institute, Dr. Josep Trueta University Hospital of Girona, Girona, Catalonia, Spain ProCURE Catalan Institute of Oncology Oncobell Bellvitge Institute for Biomedical Research (IDIBELL) L’Hospitalet del Llobregat Barcelona Spain Metabolism and Cancer Group, ProCURE (Program Against Cancer Therapeutic Resistance), Catalan Institute of Oncology, Girona, Catalonia, Spain; Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Catalonia, Spain ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Catalonia, Spain; Girona Biomedical Research Institute (IDIBGI), Girona, Spain Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, 17007 Girona, Catalonia, Spain; Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), 17190 Girona, Spain Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Catalonia, Spain; ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Catalonia, Spain ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism & Cancer Group, Catalan Institute of Oncology (ICO), Girona, Spain; Girona Biomedical Research Institute (IDIBGI), Girona, Spain Girona Biomedical Research Institute (IDIBGI), Girona, Catalonia, Spain; Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia, Spain Metabolism and Cancer Group, Program Against Cancer Therapeutic Resistance, Catalan Institute of Oncology, Girona, Spain; Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain; ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain; Girona Biomedical Research Institute (IDIBGI), Edifici M2, Parc Hospitalari Martí i Julià, Salt, Girona, Spain Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology, Girona, Spain, jmenendez@iconcologia.net. Metabolism and Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology (ICO), Girona, Spain; Girona Biomedical Research Institute (IDIBGI), Girona, Spain Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology (ICO), Girona, Catalonia, Spain; Girona Biomedical Research Institute (IDIBGI), Girona, Catalonia, Spain Fundació d’ Investigació Biomèdica de Girona Dr. Josep Trueta (J.A.M.), 17007 Girona, Catalonia, Spain; Institut Catalá d’ Oncología de Girona-Hospital Universitari de Girona Dr. Josep Trueta, Girona (J.A.M.), 170010 Catalonia, Spain Department of Medicine, Breast Cancer Translational Research Program, Evanston Northwestern Healthcare Research Institute, Evanston, Illinois; Department of Medicine, Northwestern University Feinberg School of Medicine, The Lurie Comprehensive Cancer Center, Chicago, Illinois Metabolism and Cancer Group, Program Against Cancer Therapeutic Resistance (ProCURE), Catalan Institute of Oncology, Girona 17005, Spain; Girona Biomedical Research Institute, Girona 17190, Spain Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia, Spain; Girona Biomedical Research Institute, Girona, Catalonia, Spain Translational Research Laboratory, Catalan Institute of Oncology, Girona, Spain; Girona Biomedical Research Institute, Girona, Spain Catalan Institute of Oncology-Girona, Institut d'Investigació Biomédica de Girona, Hospital Universitari de Girona, Girona, Catalonia, Spain; Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia, SPAIN; Girona Biomedical Research Institute (IDIBGI), Girona, Catalonia, SPAIN nn Girona Biomedical Research Institute (IDIBGI), Catalan Institute of Oncology (ICO) , Catalonia , Spain. From the Department of Medicine, Evanston Northwestern Healthcare Research Institute, Evanston; Department of Medicine, Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL Metabolism & Cancer Group; Translational Research Laboratory; Catalan Institute of Oncology-Girona; Molecular Oncology; Girona Biomedical Research Institute Catalan Institute of Oncology, Girona Biomedical Research Institute (IdIBGi), Avenida de Francia s/n, E-17007 Girona, Spain Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona 17005, Spain; Girona Biomedical Research Institute, Salt, Girona 17190, Spain Girona Biomedical Research Institute (IDIBGI), Girona, Spain. jmenendez@idibgi.org jmenendez@iconcologia.net. Metabolism and Cancer Group, Program Against Cancer Therapeutic Resistance, Catalan Institute of Oncology–Girona Biomedical Research Institute, Girona, Spain Translational Research Laboratory, Catalan Institute of Oncology (ICO), Girona, Spain; Girona Biomedical Research Institute (IDIBGi), Girona, Spain Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain; Girona Biomedical Research Institute (IDIBGI), Girona, Spain Catalan Institute of Oncology, Girona, Catalonia, Spain.; Girona Biomedical Research Institute, Girona, Catalonia, Spain. Girona Biomedical Research Institute (IDIBGi), Girona, Spain; ProCURE (Program Against Cancer Therapeutic Resistance), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia (Spain); Girona Biomedical Research Institute (IDIBGI), Girona, Catalonia (Spain) Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain Program Against Cancer Therapeutic Resistance(ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Catalonia, Spain; Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain Department of Medicine, Evanston Northwestern Healthcare Research Institute, Evanston, Illinois 60201, USA. jmenendez@enh.org Catalan Institute of Oncology, Health Services Division of Catalonia, Girona Biomedical Research Institute, Medical Oncology, Dr Josep Trueta University Hospital of Girona, Girona, Catalonia, Spain Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia (Spain); Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia (Spain); On behalf of the METTEN-01 Investigators (EudraClinicalTrial Number 2011-000490-30) Catalan Institute of Oncology and Girona Biomedical Research Institute Avenida de Francia S/N 17007 Girona Catalonia Spain Girona Biomedical Research Institute, Medical Oncology, Dr. Josep Trueta University Hospital of Girona, E-17007 Girona, Catalonia, Spain. jmenendez@ico.scs.es Translational Research Laboratory, Catalan Institute of Oncology (ICO), Girona, Spain; Girona Biomedical Research Institute, Girona (IDIBGi), Spain Program against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain; Girona Biomedical Research Institute (IDIBGI), Girona, Spain Metabolism and Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology (ICO), Girona, Catalonia, Spain; Molecular Oncology Group, Girona Biomedical Research Institute (IDIBGI), Girona, Catalonia, Spain Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia Spain; Girona Biomedical Research Institute (IDIBGI), Girona, Catalonia Spain |
Incoming Links
Total number of triples: 282.